79126686 - PASYLATION

Information

  • Trademark
  • 79126686
  • Serial Number
    79126686
  • Registration Number
    4483086
  • Filing Date
    October 17, 2012
    12 years ago
  • Registration Date
    February 18, 2014
    11 years ago
  • Transaction Date
    October 07, 2024
    4 months ago
  • Status Date
    October 07, 2024
    4 months ago
  • Published for Opposition Date
    December 03, 2013
    11 years ago
  • Location Date
    October 07, 2024
    4 months ago
  • Status Code
    706
  • Current Location
    Historical data usage
    Employee Name
    BEVERLY, JOSETTE
  • Attorney Docket Number
    XLPR-2000US0
    Attorney Name
    Anthony G. Craig
  • Owners
Mark Drawing Code
4
Mark Identification
PASYLATION
Case File Statements
  • GS0051: [ Pharmaceutical and veterinary preparations and preparations for human medical purposes for use in treating growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; [ sanitary preparations for medical purposes; dietetic substances adapted for medical use, namely, nutritional supplements containing proteins, peptides, food for babies; preparations for destroying vermin; fungicides, herbicides; ] pharmaceutical and diagnostic preparations for medical [, dental and forensic ] purposes and for purposes of [ forensic medicine and ] laboratory medicine, namely, pharmaceutical and diagnostic preparations for diagnosis, prevention, treatment or cure of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; testing reagents in kit form for medical, [ dental and forensic ] purposes and for purposes of [ forensic medicine and ] laboratory medicine, namely, medical [ and forensic ] diagnostic reagents and assays for testing of body tissues and body fluids; chemical and biotechnological preparations for medical and diagnostic purposes, namely, reagents and solvents for sample preparation, modification and manipulation of cells and for performing of marking, separation, isolation, purification, amplification and/or analytical methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes included in this class; medicaments for preventive, curative and palliative purposes for preventing, treating or curing of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; medical biomarkers, in particular for preventative, diagnostic, prognostic or predictive purposes, namely, polypeptide sequences; [ medical preparations, namely, kits for laboratory medicine in particular for preventive, diagnostic, prognostic or predictive purposes, namely, diagnostic kits consisting primarily of proteins, buffers, and reagents for use in detecting growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; ] biomolecules for medical purposes, namely, proteins, peptides and small molecule drugs with conjugated polypeptide sequences for binding of active substances; medical preparations for analytical purposes, namely, reagents for detecting growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases; preparations for health care, namely, for diagnosis, prevention, treatment, or cure of growth deficiencies, inflammation, infections, obesity, diabetes, malignancies, metabolic diseases, cancer, cardiovascular diseases, diseases of the CNS, eye diseases, bone diseases ]
  • PM0001: PAS YLATION
  • CC0000: Color is not claimed as a feature of the mark.
  • TR0010: The wording "PASYLATION" has no meaning in a foreign language.
  • GS0011: [ Chemicals and biochemicals for research and laboratory purposes excluding for medical or veterinary purposes, and for industrial and scientific purposes; [ unprocessed artificial resins, unprocessed plastics; ] chemical and biological preparations for medical research and medical and scientific purposes ]
  • GS0421: Scientific and technological services and research, namely, scientific research, analysis, testing, in the fields of chemistry, genetics, biology, biotechnology and biochemistry; [ technical services, namely, computer diagnostic services in the field of DNA, RNA and protein expression, detection and analysis and respective design services, in particular in the fields of chemistry, genetics, biology, biotechnology and biochemistry; industrial analysis and research services in the field of medical, dental, forensic and scientific research; design and development of computer hardware and software; ] services of a chemical and biochemical laboratory; scientific research including conducting of scientific examinations; and preparation of scientific opinions; quality checking, namely, quality evaluation services for the medical and pharmaceutical industry; [ design and development of programs for data processing; ] consultancy for scientific, laboratory and research purposes in the field of chemistry, genetics, biology, biotechnology and biochemistry; [ scientific services of a technical measuring and test laboratory; ] technological consulting services pertaining to scientific and industrial scientific research in the fields of generation, technical processing and technical analysis of biomaterials and medically relevant data
Case File Event Statements
  • 3/18/2013 - 11 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/27/2013 - 11 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/15/2013 - 11 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 3/18/2013 - 11 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/22/2013 - 11 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 9/26/2013 - 11 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/28/2013 - 11 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/28/2013 - 11 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/28/2013 - 11 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 4/23/2013 - 11 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 9/19/2013 - 11 years ago
    11 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 9/19/2013 - 11 years ago
    12 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 9/19/2013 - 11 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/20/2013 - 11 years ago
    13 - ASSIGNED TO LIE Type: ALIE
  • 9/26/2013 - 11 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/13/2013 - 11 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/13/2013 - 11 years ago
    20 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 12/3/2013 - 11 years ago
    22 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/3/2013 - 11 years ago
    23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/18/2014 - 11 years ago
    24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/18/2014 - 10 years ago
    25 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 6/6/2014 - 10 years ago
    26 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 10/29/2013 - 11 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/30/2013 - 11 years ago
    17 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 11/13/2013 - 11 years ago
    19 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 12/2/2013 - 11 years ago
    21 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 2/18/2020 - 5 years ago
    35 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/6/2014 - 10 years ago
    27 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 6/27/2014 - 10 years ago
    28 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 7/13/2017 - 7 years ago
    29 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 2/18/2019 - 6 years ago
    30 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 2/18/2020 - 5 years ago
    31 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 2/18/2020 - 5 years ago
    32 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 2/18/2020 - 5 years ago
    33 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 2/18/2020 - 5 years ago
    34 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 2/18/2020 - 5 years ago
    36 - TEAS SECTION 71 & 15 RECEIVED Type: ES75
  • 4/6/2020 - 4 years ago
    37 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 5/12/2020 - 4 years ago
    38 - POST REGISTRATION ACTION MAILED - SEC. 71 & 15 Type: PR75
  • 10/2/2020 - 4 years ago
    39 - TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Type: EROP
  • 12/29/2020 - 4 years ago
    41 - REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. Type: C75P
  • 12/27/2020 - 4 years ago
    40 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 12/29/2020 - 4 years ago
    42 - NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Type: NA75
  • 12/31/2020 - 4 years ago
    43 - INVALIDATION PROCESSED Type: INPC
  • 1/1/2021 - 4 years ago
    44 - PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INPS
  • 2/13/2021 - 4 years ago
    45 - PARTIAL INVALIDATION PROCESSED BY THE IB Type: INNP
  • 11/4/2022 - 2 years ago
    49 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL
  • 2/18/2023 - 2 years ago
    50 - COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED Type: REM4
  • 2/12/2024 - a year ago
    51 - TEAS SECTION 71 RECEIVED Type: ES71
  • 10/7/2024 - 4 months ago
    52 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 10/7/2024 - 4 months ago
    53 - REGISTERED-SEC.71 ACCEPTED Type: 71AG
  • 10/7/2024 - 4 months ago
    54 - NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Type: NA71
  • 8/29/2021 - 3 years ago
    46 - PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INPR
  • 9/9/2021 - 3 years ago
    47 - INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE Type: INNA
  • 7/2/2022 - 2 years ago
    48 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP